tiprankstipranks
Trending News
More News >

G1 Therapeutics downgraded to Hold from Buy at Needham

Needham downgraded G1 Therapeutics to Hold from Buy without a price target after the company entered into a merger agreement under which Pharmacosmos will acquire all outstanding shares of G1 for $7.15 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue